179 related articles for article (PubMed ID: 6849270)
1. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
DiMarco JP; Garan H; Ruskin JN
Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
Kim SG; Felder SD; Waspe LE; Fisher JD
Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
[TBL] [Abstract][Full Text] [Related]
4. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
Duff HJ; Gault NJ
J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
Waspe LE; Waxman HL; Buxton AE; Josephson ME
Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
[TBL] [Abstract][Full Text] [Related]
9. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
[TBL] [Abstract][Full Text] [Related]
10. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
11. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
Duff HJ; Mitchell LB; Manyari D; Wyse DG
J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB
Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426
[TBL] [Abstract][Full Text] [Related]
13. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
Flaker GC; Madigan NP; Alpert MA; Moser SA
Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
[TBL] [Abstract][Full Text] [Related]
14. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Kasanuki H; Ohnishi S; Hirosawa K
Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
[TBL] [Abstract][Full Text] [Related]
15. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
16. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Duff HJ
J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
[TBL] [Abstract][Full Text] [Related]
17. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
[TBL] [Abstract][Full Text] [Related]
19. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
DiMarco JP; Garan H; Ruskin JN
Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
